Ames-based Genvax Technologies, a startup bringing advances in self-amplifying mRNA (saRNA) for animal vaccines, will move toward getting regulatory approval of its vaccines with $6.5 million in new series seed funding. According to a press release, the company is seeking U.S. Department of Agriculture and international approval “in anticipation of any foreign animal disease outbreak in order […]